Material dependent differences in inflammatory gene expression by giant cells during the foreign body reaction
Source abstract
Abstract
Abstract Multinucleated giant cells (GCs) are often observed in the foreign body reaction against implanted materials. The in vivo function of GCs in this inflammatory process remains to be elucidated. GCs degrade collagen implants in rats and may also orchestrate the inflammatory process via the expression and secretion of modulators, such as cytokines and chemokines. In this study, we show that the gene expression of PMN chemoattractants, CXCL1/KC and CXCL2/MIP‐2, is high in GCs micro‐dissected from explanted Dacron, cross‐linked collagen (HDSC), and bioactive ureido‐pyrimidinone functionalized oligocaprolactone (bioactive PCLdiUPy). Conversely, the gene expression levels of TGFβ and pro‐angiogenic mediators VEGF and FGF were found to be low in these GCs as compared with the expression levels in total explants. GCs in bioactive PCLdiUPy displayed high cytokine and angiogenic mediator expression compared with GCs isolated from the two other studied materials, whereas chemokine gene expression in GCs isolated form HDSC was low. Thus, GCs adopt their expression profile in response to the material that is encountered. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2007
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Cell Adhesion Molecules Research · Cellular Mechanics and Interactions · Immune Response and Inflammation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (27)
Show source-provided references
1. 10.1097/00062752-200001000-0000810.1097/00062752-200001000-00008 ↗
2. 10.4049/jimmunol.158.7.338510.4049/jimmunol.158.7.3385 ↗
3. 10.1006/bbrc.1998.970210.1006/bbrc.1998.9702 ↗
4. 10.1002/jlb.60.4.50910.1002/jlb.60.4.509 ↗
5. 10.1007/BF0020065910.1007/BF00200659 ↗
6. 10.1002/jbm.82028031010.1002/jbm.820280310 ↗
7. 10.1002/path.171113010210.1002/path.1711130102 ↗
8. 10.1093/infdis/166.3.66410.1093/infdis/166.3.664 ↗
9. 10.1002/(SICI)1096-9896(199612)180:4<400::AID-PATH701>3.0.CO;2-W10.1002/(SICI)1096-9896(199612)180:4<400::AID-PATH701>3.0.CO;2-W ↗
10. 10.1046/j.1365-2567.1997.00193.x10.1046/j.1365-2567.1997.00193.x ↗
11. 10.1038/nmat141810.1038/nmat1418 ↗
12. 10.1016/0142-9612(91)90203-M10.1016/0142-9612(91)90203-M ↗
13. 10.1002/jbm.a.2006910.1002/jbm.a.20069 ↗
14. 10.1016/S1054-8807(98)00003-910.1016/S1054-8807(98)00003-9 ↗
15. 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C ↗
16. 10.1023/A:100897653159210.1023/A:1008976531592 ↗
17. 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.0.CO;2-Z10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.0.CO;2-Z ↗
18. 10.1016/S0142-9612(03)00343-010.1016/S0142-9612(03)00343-0 ↗
19. 10.1016/S0021-9258(17)31456-410.1016/S0021-9258(17)31456-4 ↗
20. 10.1016/j.biomaterials.2006.07.01110.1016/j.biomaterials.2006.07.011 ↗
21. 10.1172/JCI111210.1172/JCI1112 ↗
22. Arg‐Gly‐Asp‐Ser (RGDS) peptide stimulates transforming growth factor β1 transcription and secretion through integrin activation10.1096/fj.02-0785fje ↗
23. Regulation of interleukin 1 signalling through integrin binding and actin reorganization: Disparate effects on NF‐κB and stress kinase pathways10.1042/bj3300975 ↗
24. 10.1074/jbc.270.27.1618910.1074/jbc.270.27.16189 ↗
25. 10.1189/jlb.060325210.1189/jlb.0603252 ↗
26. 10.1016/S0021-9258(17)35666-110.1016/S0021-9258(17)35666-1 ↗
27. 10.1046/j.1365-2567.2000.00025.x10.1046/j.1365-2567.2000.00025.x ↗